DE60308810T2 - Anregung der in-vivo synthese von proteinen mit zusammensetzungen enthaltend leucin - Google Patents

Anregung der in-vivo synthese von proteinen mit zusammensetzungen enthaltend leucin Download PDF

Info

Publication number
DE60308810T2
DE60308810T2 DE60308810T DE60308810T DE60308810T2 DE 60308810 T2 DE60308810 T2 DE 60308810T2 DE 60308810 T DE60308810 T DE 60308810T DE 60308810 T DE60308810 T DE 60308810T DE 60308810 T2 DE60308810 T2 DE 60308810T2
Authority
DE
Germany
Prior art keywords
leucine
preparation
preparation according
weight
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60308810T
Other languages
German (de)
English (en)
Other versions
DE60308810D1 (de
Inventor
George Verlaan
Leonardus Rudolf SMEETS
Reese Robert League City WOLFE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nutricia NV
Original Assignee
Nutricia NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutricia NV filed Critical Nutricia NV
Application granted granted Critical
Publication of DE60308810D1 publication Critical patent/DE60308810D1/de
Publication of DE60308810T2 publication Critical patent/DE60308810T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE60308810T 2002-12-20 2003-12-15 Anregung der in-vivo synthese von proteinen mit zusammensetzungen enthaltend leucin Expired - Lifetime DE60308810T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US325711 1994-10-17
US10/325,711 US7288570B2 (en) 2002-12-20 2002-12-20 Stimulation of in vivo production of proteins
PCT/NL2003/000892 WO2004056208A1 (en) 2002-12-20 2003-12-15 Stimulation of in vivo production of proteins with formulation comprising leucine

Publications (2)

Publication Number Publication Date
DE60308810D1 DE60308810D1 (de) 2006-11-16
DE60308810T2 true DE60308810T2 (de) 2007-08-02

Family

ID=32593858

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60308810T Expired - Lifetime DE60308810T2 (de) 2002-12-20 2003-12-15 Anregung der in-vivo synthese von proteinen mit zusammensetzungen enthaltend leucin

Country Status (11)

Country Link
US (2) US7288570B2 (https=)
EP (1) EP1455603B1 (https=)
JP (1) JP2006510711A (https=)
CN (1) CN100353866C (https=)
AT (1) ATE341226T1 (https=)
AU (1) AU2003290447B2 (https=)
CA (1) CA2510760C (https=)
DE (1) DE60308810T2 (https=)
DK (1) DK1455603T3 (https=)
ES (1) ES2274299T3 (https=)
WO (1) WO2004056208A1 (https=)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4970694B2 (ja) * 2002-12-02 2012-07-11 株式会社明治 持続性筋肉疲労改善剤
US7288570B2 (en) * 2002-12-20 2007-10-30 Nutricia N.V. Stimulation of in vivo production of proteins
EA012300B1 (ru) * 2005-01-18 2009-08-28 ДСМ АйПи АССЕТС Б.В. Композиция для лечения или предотвращения сахарного диабета и ее применение
EP1774973A1 (en) * 2005-10-12 2007-04-18 Nutricia N.V. Leucine rich composition
RU2383209C2 (ru) * 2005-10-26 2010-03-10 Хилл'С Пет Ньютришн, Инк. Композиция и способы увеличения нежировой мышечной массы и/или снижения роста жира
ES2302463B1 (es) * 2006-12-29 2009-06-05 Madaus, S.A. "composicion a base de fibra de cacao".
ATE468025T1 (de) 2007-02-23 2010-06-15 Hills Pet Nutrition Inc Zusammensetzungen und verfahren für die gewichtskontrolle bei tieren
PL2098125T3 (pl) * 2008-03-03 2012-02-29 Nestec Sa Zżelowany produkt spożywczy z wysoką skutecznością przyjmowania węglowodanów
EP2098126A1 (en) * 2008-03-03 2009-09-09 Nestec S.A. Carbohydrate Bar
EP2098124A1 (en) * 2008-03-03 2009-09-09 Nestec S.A. Carbohydrate gel
WO2010002242A1 (en) 2008-07-02 2010-01-07 N.V. Nutricia Nutritional composition for improving muscle function and daily activity
EP3001912A1 (en) 2009-08-26 2016-04-06 Jeffrey M. Golini Pharmaceutical or nutraceutical composition
EP2327315B1 (en) * 2009-11-29 2013-10-09 Nestec S.A. Dosing protocols for increasing protein synthesis in an active individual
EP2327316B1 (en) * 2009-11-29 2016-11-16 Premier Nutrition Corporation Method of enhancing muscle protein synthesis
WO2011078654A1 (en) * 2009-12-24 2011-06-30 N.V. Nutricia Low-caloric high-protein nutritional composition for the stimulation of muscle protein synthesis
JP2013519869A (ja) 2010-02-10 2013-05-30 ノバルティス アーゲー 筋肉成長のための方法および化合物
CA2792396C (en) * 2010-03-12 2018-09-11 Nestec S.A. Compositions for masking the flavor of nutrients and methods for making same
WO2012005568A1 (en) 2010-07-07 2012-01-12 N.V. Nutricia Nutritional composition for the stimulation of muscle protein synthesis
US8623924B2 (en) 2011-07-15 2014-01-07 Nusirt Sciences, Inc. Compositions and methods for modulating metabolic pathways
US9198454B2 (en) 2012-03-08 2015-12-01 Nusirt Sciences, Inc. Compositions, methods, and kits for regulating energy metabolism
HK1206765A1 (en) 2012-03-26 2016-01-15 Axcella Health Inc. Nutritive fragments, proteins and methods
HK1206761A1 (en) 2012-03-26 2016-01-15 Axcella Health Inc. Nutritive fragments, proteins and methods
MX2014011459A (es) 2012-03-26 2015-02-04 Pronutria Inc Proteinas nutritivas cargadas y metodos.
EP2831100A4 (en) 2012-03-26 2016-02-10 Pronutria Inc NUTRIENT PROTEINS AND METHOD
MX2015006023A (es) 2012-11-13 2016-03-31 Nusirt Sciences Inc Composiciones y metodos para incrementar el metabolismo energetico.
CN105228627B (zh) 2013-03-15 2018-07-13 纽斯尔特科学公司 亮氨酸和烟酸降低脂质水平
US9597367B2 (en) * 2013-04-19 2017-03-21 Bioventures, Llc Methods for improving muscle and heart function
AU2013392167B2 (en) * 2013-06-10 2017-04-27 N.V. Nutricia Muscle preservation in overweight or obese adult during weight loss program
EP3048904A2 (en) 2013-09-25 2016-08-03 Pronutria Biosciences, Inc. Compositions and formulations for treatment of gastrointestinal tract malabsorption diseases and inflammatory conditions and methods of production and use thereof
EP3110507B1 (en) 2014-02-27 2020-11-18 NuSirt Sciences, Inc. Compositions and methods for the reduction or prevention of hepatic steatosis
US20170258791A1 (en) 2014-08-29 2017-09-14 Project Pm Co., Ltd. Pharmaceutical composition formed by combining pyridoxamine compound and thiamine compound
US10188135B2 (en) * 2015-11-04 2019-01-29 Stokley-Van Camp, Inc. Method for inducing satiety
RU2601406C1 (ru) * 2015-11-17 2016-11-10 Государственное Бюджетное Образовательное Учреждение Высшего Профессионального Образования "Саратовский Государственный Медицинский Университет Имени В.И. Разумовского" Министерства Здравоохранения Российской Федерации Средство, обладающее антикахексическим, противоопухолевым свойствами и снижающее уровень эндогенной интоксикации
JP6105111B1 (ja) * 2016-03-02 2017-03-29 国立大学法人東北大学 自閉スペクトラム症改善用組成物
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
IL296055A (en) 2017-08-14 2022-10-01 Axcella Health Inc Amino acid compositions for the treatment of liver disease
CH714189A1 (de) * 2017-09-25 2019-03-29 Omanda Ag Verfahren zur Herstellung von L-Leucin und Molkenprotein L-Leucin zur Nahrungsanreicherung und dessen Anwendung.
US11273138B2 (en) 2017-11-02 2022-03-15 Bioventures, Llc Use of amino acid supplementation for improved muscle protein synthesis
MA52971A (fr) 2018-06-20 2021-04-28 Axcella Health Inc Compositions et procédés pour le traitement de l'infiltration de graisse dans le muscle
CH715997A1 (de) * 2019-03-25 2020-09-30 Omanda Ag Proteingetränk und Darreichungseinheit zur Verabreichung von mit L-Leucin-angereicherten Molkenproteinkomponenten als Nahrungsanreicherung und dessen Herstellung.

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928445A (en) * 1973-12-26 1975-12-23 Allied Chem Synthesis of 2-halo-5-cyano alkyl valerate
JPS6049764A (ja) * 1983-08-29 1985-03-19 Ajinomoto Co Inc 食品組成物
JPS60186261A (ja) * 1984-03-06 1985-09-21 Ajinomoto Co Inc 固体状食品組成物
US4687782A (en) * 1984-12-10 1987-08-18 Nutri-Fuels Systems, Inc. Nutritional composition for enhancing skeletal muscle adaptation to exercise training
US5639731A (en) * 1987-05-22 1997-06-17 Pripps Bryggerier Ab Amino acids for the preparation of a beverage
FI892006L (fi) * 1988-04-29 1989-10-30 Phil Gold Lactalbumin saosom tillaeggsaemne i mat.
US5242697A (en) * 1990-10-26 1993-09-07 Maurizio Luca Method of preparing nutrified food products
JP3622271B2 (ja) 1995-07-11 2005-02-23 味の素株式会社 馬用栄養組成物
US5817329A (en) * 1997-02-28 1998-10-06 Gardiner; Paul T. Nutritional supplement for increased muscle size and strength for body builders
IT1291127B1 (it) * 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
DE29707308U1 (de) 1997-04-23 1997-06-26 Kunz, Armin, 66450 Bexbach Präparat zur Muskelerhaltung bzw. zur Förderung des Muskelaufbaus
US6051236A (en) * 1998-11-12 2000-04-18 Pacifichealth Laboratories, Inc. Composition for optimizing muscle performance during exercise
US6221418B1 (en) * 1999-03-25 2001-04-24 Focused Foods, Inc. High protein edible composition and method of preparing the same
US6241996B1 (en) * 1999-04-09 2001-06-05 Novartis Nutrition Ag Liquid soy nutritional products
EP1112693B1 (en) 1999-12-30 2006-03-22 Kerry Group Services Ltd Composition comprising carbohydrate and peptide material and its use as an energy supplement after or during physical exercise or as a metabolic nutrient for oral consumption
US6521591B1 (en) * 2000-02-10 2003-02-18 N.V. Nutricia Pharmaceutical composition for muscular anabolism
US6420342B1 (en) * 2000-05-08 2002-07-16 N.V. Nutricia Nutritional preparation comprising ribose and medical use thereof
US6706295B2 (en) * 2000-09-29 2004-03-16 The Procter & Gamble Co. Compositions comprising arabinogalactan and a defined protein component
GB0110288D0 (en) 2001-04-26 2001-06-20 Novartis Nutrition Ag Composition and treatment method
US7288570B2 (en) * 2002-12-20 2007-10-30 Nutricia N.V. Stimulation of in vivo production of proteins

Also Published As

Publication number Publication date
CA2510760A1 (en) 2004-07-08
US20040122097A1 (en) 2004-06-24
CN100353866C (zh) 2007-12-12
AU2003290447A1 (en) 2004-07-14
JP2006510711A (ja) 2006-03-30
WO2004056208A1 (en) 2004-07-08
AU2003290447A2 (en) 2005-08-25
DK1455603T3 (da) 2007-02-05
AU2003290447B2 (en) 2007-10-04
US7288570B2 (en) 2007-10-30
DE60308810D1 (de) 2006-11-16
CA2510760C (en) 2011-09-20
CN1753625A (zh) 2006-03-29
ES2274299T3 (es) 2007-05-16
US20080161398A1 (en) 2008-07-03
ATE341226T1 (de) 2006-10-15
EP1455603A1 (en) 2004-09-15
HK1065447A1 (en) 2005-02-25
EP1455603B1 (en) 2006-10-04

Similar Documents

Publication Publication Date Title
DE60308810T2 (de) Anregung der in-vivo synthese von proteinen mit zusammensetzungen enthaltend leucin
DE60019722T2 (de) Pharmazeutische zusammensetzungen zur unbehagenverminderung
DE2935709C2 (de) Aminosäurelösung zur Behandlung von an Krebs erkrankten Personen
DE69122025T2 (de) Nahrhafte Zusammensetzung
DE69110130T2 (de) Zusätze aus calcium und spurenelementen.
DE69703839T2 (de) Zusammensetzung, die als nahrungsmittel oder zur senkung des serumlipidspiegels geeignet ist
DE69325998T2 (de) Verwendung von beta-hydroxy-beta-methylbutyratsäuere zur förderung der stickstoffzurückhaltung beim menschen
EP2114174B1 (de) Verwendung von guanidinoessigsäure(-salzen) in kombination mit betain und/oder cholin zur herstellung eines gesundheitsfördernden mittels
EP2007348A1 (de) Paediatrische aminosäurelösung zur parenteralen ernährung
DE19528461A1 (de) Präparat zur Ernährung
JP2007500208A (ja) 慢性創傷の治療方法又は予防方法並びにそれに使用するためのグリシン及び／又はロイシンを含む完全栄養組成物
DE68903448T2 (de) Pharmazeutische und/oder diaetetische zusammensetzungen mit gehalt an l-carnitin und l-lysin.
DE60020833T2 (de) Melatonin zur behandlung von paralysen ausgelöst durch hirnschlag
EP1916913B1 (de) Proteinzusammensetzung zur behandlung eines physiologisch bedingten, klinisch unauffälligen proteinmehrbedarfs
DE69921346T2 (de) Pflanzenextrakte zur behandlung einer gesteigerten knochenresorption
DE102006052560B4 (de) Anti-diabetogene Calcium-Peptid-Zusammensetzung
WO2020074047A1 (de) Ketogene proteinzubereitung
EP1200082A1 (de) Präparate mit sauerstoffsparender wirkung bei körperlicher leistung
EP0920321A1 (de) Vitaminpräparate mit sauerstoffsparender wirkung bei körperlicher leistung
HK1065447B (en) Stimulation of in vivo production of proteins with formulation comprising leucine
WO2007022968A1 (de) Proteinzusammensetzung zur behandlung von proteinmangelzuständen
DE202018105839U1 (de) Ketogene Proteinzubereitung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition